Correspondence 0001193125-25-023605 from Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc.
Date: Feb. 10, 2025 · CIK: 0001755237 · Accession: 0001193125-25-023605
AI Filing Summary & Sentiment
Letter
Cyclerion Therapeutics, Inc.
245 First Street, 18th Floor
Cambridge, MA 02142
February 10, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Attention:
Chris Edwards
Re:
Cyclerion Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333- 284690)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Cyclerion Therapeutics, Inc., a Massachusetts corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 12, 2025, or as soon as possible thereafter. The Company hereby authorizes William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please contact William Michener (william.michener@ropesgray.com) / telephone: (617) 951-7247 of Ropes & Gray LLP as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
CYCLERION THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Cyclerion Therapeutics, Inc. 245 First Street, 18th Floor Cambridge, MA 02142 February 10, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Chris Edwards Re: Cyclerion Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333- 284690) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, Cyclerion Therapeutics, Inc., a Massachusetts corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on February 12, 2025, or as soon as possible thereafter. The Company hereby authorizes William Michener of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please contact William Michener (william.michener@ropesgray.com) / telephone: (617) 951-7247 of Ropes & Gray LLP as soon as the registration statement has been declared effective. [Signature page follows] Very truly yours, CYCLERION THERAPEUTICS, INC. By: /s/ Regina Graul Name: Regina Graul, Ph.D. Title: President and Chief Executive Officer [Signature Page to Acceleration Request]